Bavarian Nordic Seeks EU Approval for Adolescent Mpox Vaccine

Aug 16, 2024, 07:30 AM

Danish biotech company Bavarian Nordic has submitted data to the European Union's drug regulator seeking approval to extend the use of its mpox vaccine to adolescents. Bavarian Nordic is currently the only company with a vaccine approved for mpox in both the United States and Europe. The company aims to expand the vaccine's usage to a younger demographic, highlighting its ongoing efforts to enhance public health measures against mpox.